Remedy Robotics

Remedy Robotics is a San Francisco-based surgical robotics company developing the world's first remotely operated endovascular robotic system. Founded in 2020 by David Bell (CEO, cardiac surgeon) and Jake Sganga, the company's mission is to deliver immediate, high-quality endovascular intervention to any patient regardless of geographic location or hospital resources. The system enables trained interventionalists to perform complex endovascular procedures — including stroke and cardiovascular interventions — from a remote console, eliminating the need for specialist on-site presence. Remedy achieved multiple world firsts: fully robotic neurointerventional procedures in humans (November 2024) and the first remote neurointerventional procedures with the clinician in a separate hospital from the patient (September 2025). The company is preparing for its pivotal clinical trial and has partnered with hospitals and research institutions globally.